Report Highlights
-
The worldwide market for amino acids for synthesis is projected to rise at an AAGR (average annual growth rate) of 7% through 2009 from $713 million to $1 billion.
-
The greatest worldwide growth and the sector of the amino acids market with the highest return is the amino acids for synthesis market.
-
Biotechnology and pharmaceutical applications account for just over half of the total, but are rising fastest at an AAGR of 9.8%.
-
Amino acids for the synthesis of artificial sweeteners is poised to grow at an AAGR of 3.8% to $427 million through 2009.
INTRODUCTION
The amino acids for synthesis market is a small part of the large fine chemicals market. Further, synthesis applications for amino acids constitute a market that is separate and distinct from nutrition and animal feed. In this market, different amino acids are emphasized and their manufacturing methods tend to be different as well.
The greatest worldwide growth and the sector of the amino acids market with the highest return is the amino acids for synthesis market. This is particularly true for synthesis applications in pharmaceuticals and biotechnology, as more drugs enter into discovery and into the market that are protein based.
This report updates an earlier BCC report on the same topic that was published in February 1999. Several new applications for amino acids for synthesis have emerged since then. New technologies and a tremendous increase in patent applications impacting this market have created a need for an updated analysis
SCOPE OF STUDY
The report contains:
- Identification of synthesis applications of amino acids in the biotechnology and pharmaceutical industries
- A review of current supply sources of amino acids for synthesis applications
- Quantification of the dollar amount of amino acids being used for these applications
- Market forecasts through 2009
- An overview of amino acid synthesis technology
- Profiles of leading synthesis companies.
INFORMATION SOURCES
Information included in this report is derived from correspondence with company representatives, representatives from the U.S. department of commerce, trade association reports, company reports, and government agency statistics. An extensive literature search was performed on trade publications and on related books and articles.
ANALYST CREDENTIALS
Kecia Brown holds a B.S. in Chemistry and a MPH degree with a concentration in Epidemiology and Biostatistics. She has participated in medical research and in public health projects at universities and public health agencies. Ms. Brown has also worked in the biotechnology and pharmaceutical industries as a medical writer.
Related Reports
Recent Reports
Gene Synthesis: Technologies and Global Markets
The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.
Flow Cytometry: Products, Technologies and Global Markets
The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.
PEGylated Proteins Market
The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Top Trending Reports
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More